A sweeping study of over 13,000 citizens shows Ghanaians are ready to embrace “Made-in-Ghana” vaccines, though a critical awareness gap remains.

In a major boost to the country’s health security goals, a landmark national survey has effectively dismantled the narrative of widespread vaccine hesitancy in Ghana.

The study, conducted by the National Vaccine Institute (NVI), reveals that Ghanaians overwhelmingly view vaccines as life-saving interventions.

Dr. Sodzi Sodzi-Tettey

Even more promisingly, citizens demonstrate a powerful sense of collective responsibility toward building “vaccine sovereignty”—the ability of the nation to produce its own medical supplies independent of foreign aid.

This was contained in a press released and signed by the Chief Executive Officer of the National Vaccine Institute, Dr. Sodzi Sodzi-Tettey.

The Numbers at a Glance

The comprehensive assessment analyzed responses from more than 13,000 participants across all 16 regions and 55 districts, making it one of the most robust health perception studies ever undertaken in the country. The data paints a highly encouraging picture of national trust, though it highlights a few key areas where public education must step up before Ghana launches its own locally manufactured vaccines in 2027.
90% of respondents express outright confidence in vaccines.
94% feel a collective responsibility to ensure vaccine availability.
88% place absolute trust in the frontline doctors and nurses who administer them.
71% say they are fully ready to accept and use vaccines manufactured right here in Ghana.
This deep institutional trust extends to regulatory bodies like the Ghana Health Service (GHS) and the Food and Drugs Authority (FDA), giving the government a solid foundation to build upon.
Low Awareness of 2027 Launch

Despite the public’s eagerness to support local science, the NVI uncovered a critical communication gap where only 14 percent of Ghanaians actually know that the country is actively building local vaccine manufacturing capacity.

“Ghana has a strong foundation of vaccine confidence, but success depends on bridging the awareness and trust gap for locally manufactured vaccines,” warns Dr. Sodzi Sodzi-Tettey, CEO of the National Vaccine Institute. “What is needed now is targeted policy and communication strategies to address misinformation, cost barriers, and regional disparities.”
Interestingly, the data exposed a sharp urban-rural divide:
Urban centers (like Greater Accra, Central, and Ashanti regions) showed lower vaccine acceptance rates, despite people having easier access to information.
Rural communities some regions in the North and Oti demonstrated significantly stronger trust and acceptance.

Overcoming the Barriers

While national pride is high—with many respondents stating that seeing Ghanaian scientists running local factories would heavily boost their confidence—practical hurdles still remain.
The survey identified three major roadblocks that could hinder success at the point of delivery:
The physical distance to vaccination centers.
Potential cost barriers for citizens.
Worries over the reliability of “cold chain” infrastructure (the refrigerated transport and storage needed to keep vaccines safe), especially in remote rural areas.
In response, the NVI and its partners are already drawing up plans to fortify rural storage networks and maintain transparent handling protocols to keep the public’s trust intact.

A turning point

The timing of this data is vital since Ghana’s pharmaceutical sector is in the middle of a historic transition toward self-sufficiency.
By scaling up production by 2027, Ghana isn’t just securing its own health future; it is also spearheading a broader African Union vision. The Partnerships for African Vaccine Manufacturing (PAVM) aims to have the continent locally produce at least 60 percent of its own vaccines by the year 2040.
Backed by the GHS, the FDA, and the World Health Organization (WHO), the NVI is now preparing to roll out a massive, nationwide public awareness campaign. This initiative will bring together community leaders, civil society, the media, and healthcare workers to ensure that when the first Ghanaian-made vial leaves the factory line, the nation is fully ready to embrace it.By Akosua Frema Frempong
.